ProSalud in Latinos Living in Rural/Agricultural Communities Within Moffitt's Catchment Area
Public ClinicalTrials.gov record NCT07218848. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
ProSalud: A Health Promotion Project to Reduce Cancer Risk in Latinos Living in Rural/Agricultural Communities Within Moffitt's Catchment Area
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to find out if Latino families living in rural parts of Florida are interested in learning about cancer prevention through our ProSalud program and whether it helps them make healthier choices to lower their risk of cancer. The study will also gather people's opinions about the program to find ways to improve it in the future. For the first part of our study, Latino parents with children between the ages of 6 and 12 will be invited to take part in a one-hour (or one-and-a-half-hour) workshop. The workshop will teach about healthy habits like eating well, being active, and protecting skin from the sun. For the second part of the study, some parents who participated in the workshops will be randomly chosen to join a focus group. In the focus group, they'll be asked questions to help us make the workshop better and make sure it fits the culture, needs, and preferences of Latino families in rural communities.
Study identification
- NCT ID
- NCT07218848
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 52 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 21, 2025
- Primary completion
- Mar 31, 2027
- Completion
- Mar 31, 2027
- Last update posted
- May 21, 2026
2025 – 2027
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Moffitt Cancer Center | Tampa | Florida | 33612 | — |
| University of South Florida | Tampa | Florida | 33612 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07218848, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 21, 2026 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07218848 live on ClinicalTrials.gov.